table of content
1 HIV Therapy Market Overview
1.1 Product Overview and Scope of HIV Therapy
1.2 HIV Therapy Segment by Drug Type
1.2.1 Global HIV Therapy Sales Growth Rate Comparison by Drug Type (2022-2028)
1.2.2 Integrase Inhibitors
1.2.3 Non- Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
1.2.4 Combination HIV Medicines
1.2.5 Others
1.3 HIV Therapy Segment by Application
1.3.1 Global HIV Therapy Sales Comparison by Application: (2022-2028)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.3.5 Others
1.4 Global HIV Therapy Market Size Estimates and Forecasts
1.4.1 Global HIV Therapy Revenue 2017-2028
1.4.2 Global HIV Therapy Sales 2017-2028
1.4.3 HIV Therapy Market Size by Region: 2017 Versus 2021 Versus 2028
2 HIV Therapy Market Competition by Manufacturers
2.1 Global HIV Therapy Sales Market Share by Manufacturers (2017-2022)
2.2 Global HIV Therapy Revenue Market Share by Manufacturers (2017-2022)
2.3 Global HIV Therapy Average Price by Manufacturers (2017-2022)
2.4 Manufacturers HIV Therapy Manufacturing Sites, Area Served, Product Type
2.5 HIV Therapy Market Competitive Situation and Trends
2.5.1 HIV Therapy Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest HIV Therapy Players Market Share by Revenue
2.5.3 Global HIV Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 HIV Therapy Retrospective Market Scenario by Region
3.1 Global HIV Therapy Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global HIV Therapy Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America HIV Therapy Market Facts & Figures by Country
3.3.1 North America HIV Therapy Sales by Country
3.3.2 North America HIV Therapy Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe HIV Therapy Market Facts & Figures by Country
3.4.1 Europe HIV Therapy Sales by Country
3.4.2 Europe HIV Therapy Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific HIV Therapy Market Facts & Figures by Region
3.5.1 Asia Pacific HIV Therapy Sales by Region
3.5.2 Asia Pacific HIV Therapy Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America HIV Therapy Market Facts & Figures by Country
3.6.1 Latin America HIV Therapy Sales by Country
3.6.2 Latin America HIV Therapy Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa HIV Therapy Market Facts & Figures by Country
3.7.1 Middle East and Africa HIV Therapy Sales by Country
3.7.2 Middle East and Africa HIV Therapy Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global HIV Therapy Historic Market Analysis by Drug Type
4.1 Global HIV Therapy Sales Market Share by Drug Type (2017-2022)
4.2 Global HIV Therapy Revenue Market Share by Drug Type (2017-2022)
4.3 Global HIV Therapy Price by Drug Type (2017-2022)
5 Global HIV Therapy Historic Market Analysis by Application
5.1 Global HIV Therapy Sales Market Share by Application (2017-2022)
5.2 Global HIV Therapy Revenue Market Share by Application (2017-2022)
5.3 Global HIV Therapy Price by Application (2017-2022)
6 Key Companies Profiled
6.1 ViiV Healthcare
6.1.1 ViiV Healthcare Corporation Information
6.1.2 ViiV Healthcare Description and Business Overview
6.1.3 ViiV Healthcare HIV Therapy Sales, Revenue and Gross Margin (2017-2022)
6.1.4 ViiV Healthcare HIV Therapy Product Portfolio
6.1.5 ViiV Healthcare Recent Developments/Updates
6.2 Gilead Sciences, Inc.
6.2.1 Gilead Sciences, Inc. Corporation Information
6.2.2 Gilead Sciences, Inc. Description and Business Overview
6.2.3 Gilead Sciences, Inc. HIV Therapy Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Gilead Sciences, Inc. HIV Therapy Product Portfolio
6.2.5 Gilead Sciences, Inc. Recent Developments/Updates
6.3 GlaxoSmithKline Plc
6.3.1 GlaxoSmithKline Plc Corporation Information
6.3.2 GlaxoSmithKline Plc Description and Business Overview
6.3.3 GlaxoSmithKline Plc HIV Therapy Sales, Revenue and Gross Margin (2017-2022)
6.3.4 GlaxoSmithKline Plc HIV Therapy Product Portfolio
6.3.5 GlaxoSmithKline Plc Recent Developments/Updates
6.4 Merck Sharp & Dohme Corp.
6.4.1 Merck Sharp & Dohme Corp. Corporation Information
6.4.2 Merck Sharp & Dohme Corp. Description and Business Overview
6.4.3 Merck Sharp & Dohme Corp. HIV Therapy Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Merck Sharp & Dohme Corp. HIV Therapy Product Portfolio
6.4.5 Merck Sharp & Dohme Corp. Recent Developments/Updates
6.5 Bristol-Myers Squibb Company
6.5.1 Bristol-Myers Squibb Company Corporation Information
6.5.2 Bristol-Myers Squibb Company Description and Business Overview
6.5.3 Bristol-Myers Squibb Company HIV Therapy Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Bristol-Myers Squibb Company HIV Therapy Product Portfolio
6.5.5 Bristol-Myers Squibb Company Recent Developments/Updates
6.6 Janssen Pharmaceuticals, Inc.
6.6.1 Janssen Pharmaceuticals, Inc. Corporation Information
6.6.2 Janssen Pharmaceuticals, Inc. Description and Business Overview
6.6.3 Janssen Pharmaceuticals, Inc. HIV Therapy Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Janssen Pharmaceuticals, Inc. HIV Therapy Product Portfolio
6.6.5 Janssen Pharmaceuticals, Inc. Recent Developments/Updates
6.7 Boehringer Ingelheim International GmbH
6.6.1 Boehringer Ingelheim International GmbH Corporation Information
6.6.2 Boehringer Ingelheim International GmbH Description and Business Overview
6.6.3 Boehringer Ingelheim International GmbH HIV Therapy Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Boehringer Ingelheim International GmbH HIV Therapy Product Portfolio
6.7.5 Boehringer Ingelheim International GmbH Recent Developments/Updates
6.8 AbbVie Inc.
6.8.1 AbbVie Inc. Corporation Information
6.8.2 AbbVie Inc. Description and Business Overview
6.8.3 AbbVie Inc. HIV Therapy Sales, Revenue and Gross Margin (2017-2022)
6.8.4 AbbVie Inc. HIV Therapy Product Portfolio
6.8.5 AbbVie Inc. Recent Developments/Updates
6.9 Genentech, Inc.
6.9.1 Genentech, Inc. Corporation Information
6.9.2 Genentech, Inc. Description and Business Overview
6.9.3 Genentech, Inc. HIV Therapy Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Genentech, Inc. HIV Therapy Product Portfolio
6.9.5 Genentech, Inc. Recent Developments/Updates
6.10 Mylan N.V.
6.10.1 Mylan N.V. Corporation Information
6.10.2 Mylan N.V. Description and Business Overview
6.10.3 Mylan N.V. HIV Therapy Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Mylan N.V. HIV Therapy Product Portfolio
6.10.5 Mylan N.V. Recent Developments/Updates
7 HIV Therapy Manufacturing Cost Analysis
7.1 HIV Therapy Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of HIV Therapy
7.4 HIV Therapy Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 HIV Therapy Distributors List
8.3 HIV Therapy Customers
9 HIV Therapy Market Dynamics
9.1 HIV Therapy Industry Trends
9.2 HIV Therapy Market Drivers
9.3 HIV Therapy Market Challenges
9.4 HIV Therapy Market Restraints
10 Global Market Forecast
10.1 HIV Therapy Market Estimates and Projections by Drug Type
10.1.1 Global Forecasted Sales of HIV Therapy by Drug Type (2023-2028)
10.1.2 Global Forecasted Revenue of HIV Therapy by Drug Type (2023-2028)
10.2 HIV Therapy Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of HIV Therapy by Application (2023-2028)
10.2.2 Global Forecasted Revenue of HIV Therapy by Application (2023-2028)
10.3 HIV Therapy Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of HIV Therapy by Region (2023-2028)
10.3.2 Global Forecasted Revenue of HIV Therapy by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
